Table 4 Age-stratified analysis of the relationship between serum Klotho levels and epilepsy prevalence.
From: Serum Klotho levels and epilepsy among U.S. adults in the NHANES 2013–2016: a cross-sectional study
Group | Characteristic | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | ||
< 65 years | Klotho | ||||||
Tertile 1 | Reference | Reference | Reference | ||||
Tertile 2 | 0.89 (0.74, 1.07) | 0.199 | 0.86 (0.72, 1.03) | 0.110 | 0.87 (0.72, 1.07) | 0.186 | |
Tertile 3 | 0.69 (0.57, 0.83) | < 0.001 | 0.69 (0.57, 0.83) | < 0.001 | 0.69 (0.57, 0.83) | < 0.001 | |
P for trend | < 0.001 | < 0.001 | < 0.001 | ||||
≥ 65 years | Klotho | ||||||
Tertile 1 | Reference | Reference | Reference | ||||
Tertile 2 | 0.97 (0.74, 1.28) | 0.842 | 0.97 (0.74, 1.28) | 0.839 | 0.96 (0.73, 1.26) | 0.762 | |
Tertile 3 | 0.89 (0.67, 1.18) | 0.417 | 0.89 (0.67, 1.19) | 0.441 | 0.91 (0.69, 1.22) | 0.528 | |
P for trend | 0.714 | 0.739 | 0.814 | ||||